Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes
The Science Underlying COVID-19: Implications for the Cardiovascular System
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)